<DOC>
	<DOCNO>NCT00004363</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine whether diverse mutation vasopressin-neurophysin II ( AVP-NPII ) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus direct production abnormal preprohormone . II . Determine whether AVP-NPII gene-directed preprohormone accumulate destroy magnocellular neuron fold process efficiently .</brief_summary>
	<brief_title>Study Pathogenesis Pathophysiology Familial Neurohypophyseal Diabetes Insipidus</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This project involve 2 clinical study . Members know kindred participate Study I ; member kindred survey , genotyped , phenotyped participate Study II . In Study I , participant undergo clinical , hormonal , radiologic , biochemical study . Assessment unrestricted fluid intake include body weight , urine volume , osmolality , creatinine , sodium , potassium , urea , glucose , arginine-vasopressin ( AVP ) , oxytocin , aquaporin-II . Participants diabetes insipidus ( DI ) undergo standard fluid deprivation test ; without DI undergo standard water load hypertonic saline test . Previously untreated DI patient may give intranasal subcutaneous desmopressin oral chlorpropamide ( adult ) 2 3 day . Magnetic resonance image pituitary-hypothalamic area perform patient without gadolinium . Infants child study annually first 5 year develop DI . Affected adult study every 2-5 year . Unaffected adults re-tested subsequently report de novo symptom suggestive DI . In Study II , participant undergo similar genotype phenotype test . Kindreds demonstrate familial neurohypophyseal diabetes insipidus phenotype genotype add Study I. Kindreds find different type DI direct companion protocol .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Insipidus</mesh_term>
	<mesh_term>Diabetes Insipidus , Neurogenic</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<mesh_term>Arginine Vasopressin</mesh_term>
	<mesh_term>Chlorpropamide</mesh_term>
	<criteria>Verified suspect familial neurohypophyseal diabetes insipidus without identify mutation vasopressinneurophysin II gene Affected unaffected member kindred enter</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>diabetes insipidus</keyword>
	<keyword>endocrine disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>